Wag! (PET) 10-Q 13 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 07, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-40764
Entity Registrant Name	Wag! Group Co.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	88-3590180
Entity Address, Address Line One	2261 Market Street
Entity Address, Address Line Two	Suite 86056
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94114
City Area Code	707
Local Phone Number	324-4219
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		49,791,120
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Entity Central Index Key	0001842356
Common Stock, par value $0.0001 per share
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	PET
Security Exchange Name	NASDAQ
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
Trading Symbol	PETWW
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 8,445	$ 18,323
Accounts receivable, net	6,548	10,023
Prepaid expenses and other current assets	3,258	3,428
Total current assets	18,251	31,774
Property and equipment, net	1,515	347
Operating lease right-of-use assets	816	1,045
Intangible assets, net	7,312	8,828
Goodwill	4,646	4,646
Other assets	52	57
Total assets	32,592	46,697
Current liabilities:
Accounts payable	5,252	9,919
Accrued expenses and other current liabilities	3,184	4,015
Deferred revenue	1,778	1,781
Deferred purchase consideration – current portion	0	547
Operating lease liabilities – current portion	401	386
Notes payable – current portion, net of debt discount and warrant allocation of $1,730 as of September 30, 2024	19,015	1,751
Total current liabilities	29,630	18,399
Operating lease liabilities – non-current portion	556	816
Notes payable – non-current portion, net of debt discount and warrant allocation of $4,563 as of December 31, 2023	0	25,664
Other non-current liabilities	31	172
Total liabilities	30,217	45,051
Commitments and contingencies (Note 8)
Stockholders’ equity:
Common stock, $0.0001 par value; 110,000 shares authorized as of both September 30, 2024 and December 31, 2023; 49,785 and 39,597 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	4	4
Additional paid-in capital	176,859	163,376
Accumulated deficit	(174,488)	(161,734)
Total stockholders’ equity	2,375	1,646
Total liabilities and stockholders’ equity	$ 32,592	$ 46,697

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Debt discount and warrant allocation, current	$ 1,730
Debt discount and warrant allocation, noncurrent		$ 4,563
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	110,000	110,000
Common stock, issued (in shares)	49,785	39,597
Common stock, outstanding (in shares)	49,785	39,597

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues	$ 13,204	$ 21,800	$ 55,074	$ 62,243
Costs and expenses:
Cost of revenues (exclusive of depreciation and amortization shown separately below)	1,146	1,441	3,874	3,710
Platform operations and support	2,798	2,968	8,472	9,630
Sales and marketing	8,862	12,755	35,554	36,788
Royalty	0	0	0	1,791
General and administrative	4,231	4,682	12,279	14,487
Depreciation and amortization	583	414	1,741	1,170
Total costs and expenses	17,620	22,260	61,920	67,576
Interest expense	1,497	1,915	4,979	5,686
Interest income	(105)	(232)	(332)	(714)
Loss on extinguishment of debt	454	0	1,180	0
Other expense, net	0	12	0	21
Loss before income taxes	(6,262)	(2,155)	(12,673)	(10,326)
Income taxes	0	41	81	79
Equity in net earnings of equity method investments	0	0	0	553
Net loss	$ (6,262)	$ (2,196)	$ (12,754)	$ (9,852)
Loss per share, basic (in dollars per share)	$ (0.13)	$ (0.06)	$ (0.30)	$ (0.26)
Loss per share, diluted (in dollars per share)	$ (0.13)	$ (0.06)	$ (0.30)	$ (0.26)
Weighted-average common shares outstanding used in computing loss per share, basic (in shares)	47,780	38,987	42,941	38,061
Weighted-average common shares outstanding used in computing loss per share, diluted (in shares)	47,780	38,987	42,941	38,061

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		36,849
Beginning balance at Dec. 31, 2022	$ 9,922	$ 4	$ 158,335	$ (148,417)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and vesting of restricted stock units (in shares)		580
Issuance of common stock from exercise of stock options and vesting of restricted stock units	54		54
Stock-based compensation	1,342		1,342
Net loss	(3,787)			(3,787)
Balance at the end (in shares) at Mar. 31, 2023		37,429
Ending balance at Mar. 31, 2023	7,531	$ 4	159,731	(152,204)
Beginning balance (in shares) at Dec. 31, 2022		36,849
Beginning balance at Dec. 31, 2022	9,922	$ 4	158,335	(148,417)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(9,852)
Balance at the end (in shares) at Sep. 30, 2023		39,238
Ending balance at Sep. 30, 2023	3,923	$ 4	162,188	(158,269)
Beginning balance (in shares) at Mar. 31, 2023		37,429
Beginning balance at Mar. 31, 2023	7,531	$ 4	159,731	(152,204)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options (in shares)		1,298
Issuance of common stock from exercise of stock options	36		36
Stock-based compensation	1,121		1,121
Shares issued for acquisition (in shares)		49
Shares issued for acquisition	225		225
Net loss	(3,869)			(3,869)
Balance at the end (in shares) at Jun. 30, 2023		38,776
Ending balance at Jun. 30, 2023	5,044	$ 4	161,113	(156,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and vesting of restricted stock units (in shares)		462
Issuance of common stock from exercise of stock options and vesting of restricted stock units	10		10
Stock-based compensation	1,065		1,065
Net loss	(2,196)			(2,196)
Balance at the end (in shares) at Sep. 30, 2023		39,238
Ending balance at Sep. 30, 2023	3,923	$ 4	162,188	(158,269)
Beginning balance (in shares) at Dec. 31, 2023		39,597
Beginning balance at Dec. 31, 2023	1,646	$ 4	163,376	(161,734)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and vesting of restricted stock units (in shares)		943
Issuance of common stock from exercise of stock options and vesting of restricted stock units	61		61
Stock-based compensation	1,296		1,296
Net loss	(4,241)			(4,241)
Balance at the end (in shares) at Mar. 31, 2024		40,540
Ending balance at Mar. 31, 2024	(1,238)	$ 4	164,733	(165,975)
Beginning balance (in shares) at Dec. 31, 2023		39,597
Beginning balance at Dec. 31, 2023	$ 1,646	$ 4	163,376	(161,734)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options (in shares)	1,110
Net loss	$ (12,754)
Balance at the end (in shares) at Sep. 30, 2024		49,785
Ending balance at Sep. 30, 2024	2,375	$ 4	176,859	(174,488)
Beginning balance (in shares) at Mar. 31, 2024		40,540
Beginning balance at Mar. 31, 2024	(1,238)	$ 4	164,733	(165,975)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and vesting of restricted stock units (in shares)		808
Issuance of common stock from exercise of stock options and vesting of restricted stock units	48		48
Stock-based compensation	1,656		1,656
Shares issued for acquisition (in shares)		46
Net loss	(2,251)			(2,251)
Balance at the end (in shares) at Jun. 30, 2024		41,394
Ending balance at Jun. 30, 2024	(1,785)	$ 4	166,437	(168,226)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and vesting of restricted stock units (in shares)		984
Issuance of common stock from exercise of stock options and vesting of restricted stock units	5		5
Stock-based compensation	1,847		1,847
Issuance of common stock upon registered public offering, net of issuance costs (in shares)		7,407
Issuance of common stock upon registered public offering, net of issuance costs	8,570		8,570
Net loss	(6,262)			(6,262)
Balance at the end (in shares) at Sep. 30, 2024		49,785
Ending balance at Sep. 30, 2024	$ 2,375	$ 4	$ 176,859	$ (174,488)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flow from operating activities:
Net loss	$ (12,754)	$ (9,852)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	4,799	3,528
Non-cash interest expense	1,768	2,021
Depreciation and amortization	1,741	1,170
Reduction in carrying amount of operating lease right-of-use assets	229	256
Equity in net earnings of equity method investments	0	(553)
Loss on extinguishment of debt	1,180	0
Other	0	12
Changes in operating assets and liabilities, net of effect of acquired business:
Accounts receivable	3,475	(2,573)
Prepaid expenses and other current assets	170	(463)
Other assets	5	1
Accounts payable	(4,667)	2,762
Accrued expenses and other current liabilities	(831)	(452)
Deferred revenue	(3)	(491)
Operating lease liabilities	(245)	(208)
Other non-current liabilities	(141)	218
Net cash used in operating activities	(5,274)	(4,624)
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired	(128)	(9,152)
Cash paid for equity method investment	0	(1,470)
Purchase of property and equipment	(1,265)	(40)
Net cash used in investing activities	(1,393)	(10,662)
Cash flows from financing activities:
Repayment of debt	(11,233)	(907)
Debt prepayment penalty	(100)	0
Proceeds from exercises of stock options	114	100
Proceeds from registered public offering of common stock, net of issuance costs	8,570	0
Other	(562)	(569)
Net cash used in financing activities	(3,211)	(1,376)
Net change in cash and cash equivalents	(9,878)	(16,662)
Cash and cash equivalents, beginning of period	18,323	38,966
Cash and cash equivalents, end of period	$ 8,445	$ 22,304

Organization and Description of

Organization and Description of Business	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Wag! Group Co. (“Wag!,” “Wag,” the “Company,” “we,” or “our”), formerly known as CHW Acquisition Corporation (“CHW”), is incorporated in Delaware with headquarters in San Francisco, California. The Company develops and supports proprietary technologies available via website and mobile app (“platform” or “marketplace”) that enable end users, such as Pet Parents, to connect with independent service and product providers to obtain services and products. The Company operates in the United States.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation The unaudited condensed consolidated interim financial information of the Company has been prepared in accordance with Article 10 of the Securities and Exchange Commission’s (“SEC”) Regulation S-X. Accordingly, as permitted by Article 10 of Regulation S-X, it does not include all of the information required by generally accepted accounting principles in the U.S. (“U.S. GAAP”) for complete financial statements. The condensed consolidated balance sheet as of December 31, 2023 was derived from the audited financial statements at that date and does not include all the disclosures required by U.S. GAAP, as permitted by Article 10 of Regulation S-X. The Company’s unaudited condensed consolidated financial statements as of September 30, 2024 and for the three and nine months ended September 30, 2024 and 2023 include Wag! Group Co. and all of its subsidiaries. In the opinion of management, the accompanying financial information contains all adjustments, consisting of normal recurring adjustments, necessary to state fairly the Company’s unaudited condensed consolidated financial statements as of September 30, 2024 and for the three and nine months ended September 30, 2024 and 2023. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 10-K”). Operating results for the three and nine months ended September 30, 2024 and 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. Liquidity and Going Concern Pursuant to the requirements of FASB ASC Topic 205-40, Presentation of Financial Statements—Going Concern , management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these financial statements are issued. This evaluation does not take into consideration the potential mitigating effect of management's plans that have not been fully implemented or are not within control of the Company as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company's ability to continue as a going concern. The mitigating effect of management's plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued. As of September 30, 2024, the Company had cash and cash equivalents of approximately $8.4 million and accounts receivable of $6.5 million, and the amount outstanding under its debt obligations was $20.7 million, of which $20.3 million and $0.4 million related to the Financing Agreement and PPP Loan, respectively. Additionally, for the nine months ended September 30, 2024, net loss was $12.8 million and net cash used in operating activities was $5.3 million. The Company’s ability to continue as a going concern is dependent on its ability to generate significant cash flows, obtain sufficient proceeds from any future offerings of securities, renegotiate the existing terms of the Financing Agreement, and/or obtain alternative financing prior to the maturity of the Financing Agreement in August 2025. The Company expects operating losses to continue in the foreseeable future as it continues to invest in growing its business. To alleviate these conditions, the Company completed a registered public offering of common stock in July 2024 for net proceeds of approximately $8.6 million (See Note 9, Stockholders’ Equity (Deficit) , for more information) and management is actively engaged in discussions to refinance the Financing Agreement. However, there can be no assurance that the Company will be able to complete the refinancing as it is ultimately outside of the control of the Company. Due to the Company’s projected cash needs (which includes amounts due under the Financing Agreement) combined with its current liquidity level and history of net losses and cash used to fund operating activities, there is substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least one year from the date of issuance of these unaudited condensed consolidated financial statements. The accompanying unaudited condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. This also means that the accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of the uncertainties described above, which could be material. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenues and expenses. Actual results could differ from those estimates. Significant items subject to estimates and assumptions include, but are not limited to, fair values of financial instruments, valuation of intangible assets acquired, valuation of stock-based compensation and warrants, and the valuation allowance for deferred income taxes. Actual results may differ from these estimates. Recently Adopted Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). This ASU simplifies the accounting for convertible instruments by eliminating certain accounting models, resulting in fewer embedded conversion features being separately recognized from the host contract, and also amends the guidance for derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. Additionally, the amendments in this ASU affect the diluted earnings per share (“EPS”) calculation for convertible instruments. It requires that the effect of potential share settlement be included in the diluted EPS calculation when a convertible instrument may be settled in cash or shares; the if-converted method as opposed to the treasury stock method is required to calculate diluted EPS for these types of convertible instruments. The amendments in this update are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The adoption of this guidance during the first quarter of 2024 did not have a material impact on the Company’s condensed consolidated financial statements. New Accounting Pronouncements In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). This ASU improves reportable segment disclosures, primarily through enhanced disclosures about significant segment expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the potential impact of this adoption on its condensed consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). This ASU improves the transparency of income tax disclosures by requiring: (1) consistent categories and greater disaggregation of information in the rate reconciliation, and (2) income taxes paid disaggregated by jurisdiction. Additionally, the amendments in this ASU improve the effectiveness and comparability of disclosures by: (1) adding disclosures of pretax income (or loss) and income tax expense (or benefit) to be consistent with U.S. Securities and Exchange Commission (“SEC”) Regulation S-X, and (2) removing disclosures that no longer are considered cost beneficial or relevant. The amendments in this update are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the potential impact of this adoption on its condensed consolidated financial statements. In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”). This ASU improves financial reporting by requiring that public business entities disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods that is generally not presented in the financial statements today. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is evaluating the potential impact of this adoption on its condensed consolidated financial statements. Equity Method Investment During the fourth quarter of 2022, the Company’s subsidiary, Compare Pet Insurance Services, Inc., entered into an agreement to invest $1.5 million for 49% ownership in a new limited liability company, which was funded in the first quarter of 2023. The investment was accounted for as an equity method investment, with the Company’s proportionate share of the investee’s net income recognized in equity in net earnings of equity method investment within the Company’s consolidated statement of operations, as the Company had less than 50% ownership and did not control the entity. During the nine months ended September 30, 2024, the Company did not recognize any activity within its condensed consolidated statements of operations related to the equity method investee. During the third quarter of 2023, the Company acquired the remaining 51% ownership of the limited liability company for an aggregate purchase price of approximately $2.2 million. The Company accounted for the transaction as an asset acquisition using the cost accumulation model to determine the cost to be allocated to the assets acquired, which resulted in the derecognition of royalties payable to the equity method investee of approximately $1.8 million and the recognition of intangible assets acquired of approximately $0.2 million and cash acquired of $2.5 million. As a result of the transaction, the limited liability company became a wholly-owned subsidiary of the Company and the Company began consolidating the entity as part of its condensed consolidated financial statements. Revenue Recognition The Company recognizes revenue in accordance with FASB Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers . Through its Services offerings, the Company principally generates Services revenue from service fees charged to Pet Caregivers to successfully complete a pet care service for a Pet Parent via the platform. The Company also generates revenue from subscription fees paid by Pet Parents for Wag! Premium and fees paid by Pet Caregivers to join the platform. Additionally, through its Wellness and Pet Food & Treat offerings, the Company generates revenue through commission fees paid by third-party service partners in the form of “revenue-per-action” or conversion activity defined in our agreements with the respective third-party service partner. For some of the Company’s arrangements with third-party service partners, the transaction price is considered variable, and an estimate of the transaction price is recorded when the action occurs. The estimated transaction price used in the variable consideration is based on historical data with the respective third-party service partner and the consideration is measured and settled monthly. The Company enters into terms of service with Pet Caregivers and Pet Parents to use the platform (“Terms of Service Agreements”), as well as an Independent Contractor Agreement (“ICA”) with Pet Caregivers (the ICA, together with the Terms of Service Agreements, the “Agreements”). The Agreements govern the fees the Company charges the Pet Caregivers and Pet Parents, where applicable, for each transaction. Upon acceptance of a transaction, Pet Caregivers agree to perform the services that are requested by a Pet Parent. The acceptance of a transaction request combined with the Agreements establishes enforceable rights and obligations for each transaction. A contract exists between the Company and its customers after both the Pet Caregivers and Pet Parent accept a transaction request and the Pet Caregivers ability to cancel the transaction lapses. For Wag! Wellness and Pet Food & Treat revenues, the Company enters into agreements with third-party service partners which define the action by a Pet Parent that results in the Company earning and receiving a commission fee from the third-party service partner. Wag!’s service obligations are performed, and revenue is recognized, for fees earned related to the facilitation and completion of a pet service transaction between the Pet Parent and the Pet Caregiver through the use of our platform. Revenue generated from the Company’s Wag! Premium subscription is recognized on a ratable basis over the contractual period, which is generally one month to one year depending on the type of subscription purchased by the Pet Parent. Prepaid subscription amounts are included in deferred revenue within the Company’s condensed consolidated balance sheets. Revenue related to the fees paid by the Pet Caregiver to join the platform are recognized upon processing of the applications. Wag! Wellness and Pet Food & Treat revenue performance obligations are completed, and revenue is recognized, when an end-user completes an action or conversion activity. Principal vs. Agent Considerations Judgment is required in determining whether the Company is the principal or agent in transactions with Pet Caregivers and Pet Parents. The Company evaluates the presentation of revenues on a gross or net basis based on whether the Company controls the service provided to the Pet Parent and is the principal (i.e., “gross”), or whether the Company arranges for other parties to provide the service to the Pet Parent and is an agent (i.e. “net”). The Company’s role in a transaction on the platform is to facilitate Pet Caregivers finding, applying, and completing a successful pet care service for a Pet Parent. The Company has concluded it is the agent in transactions with Pet Caregivers and Pet Parents because, among other factors, the Company’s role is to facilitate pet service opportunities; it is not responsible for and does not control the delivery of pet services provided by the Pet Caregivers to the Pet Parents. Gift Cards The Company sells gift cards that can be redeemed by Pet Parents through the platform. Proceeds from the sale of gift cards are deferred and recorded as contract liabilities in Deferred revenue within the Company’s condensed consolidated balance sheets until Pet Parents use the card to place orders on our platform. When gift cards are redeemed, revenue is recognized on a net basis as the difference between the amounts collected from the purchaser less amounts remitted to Pet Caregivers. Unused gift cards are included in Deferred revenue within the Company’s condensed consolidated balance sheets. The Company recognizes breakage revenue based on historical redemption patterns. Incentives The Company offers discounts and promotions to encourage use of the Company’s platform. These promotions are generally pricing actions in the form of discounts that reduce the price Pet Parents pay Pet Caregivers for services. These promotions result in a lower fee earned by the Company from the Pet Caregiver. Accordingly, the Company records the cost of these promotions as a reduction of revenues. Discounts on services offered through our subscription program are also recorded as a reduction of revenues. Loss Per Share The Company follows the two-class method when computing loss per share when shares issued meet the definition of participating securities. The two-class method determines loss per share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.

Business Combination with CHW

Business Combination with CHW	9 Months Ended
	Sep. 30, 2024
Business Combination And Reverse Recapitalization [Abstract]
Business Combination with CHW	Business Combination with CHW On August 9, 2022 (the “Merger Date”), Wag! Labs, Inc. (“Legacy Wag!”), CHW Acquisition Corporation (“CHW”), and CHW Merger Sub, Inc. (“Merger Sub”) pursuant to the terms of the Business Combination Agreement and Plan of Merger (the “CHW Business Combination Agreement”) dated February 2, 2022, completed the business combination of Legacy Wag! and CHW which was effected by the merger of Merger Sub with and into Legacy Wag!, with Legacy Wag! surviving the Merger as a wholly-owned subsidiary of CHW (the “Merger,” and, together with the other transactions contemplated by the CHW Business Combination Agreement, the “CHW Business Combination”). Upon completion of the Merger on August 9, 2022, following the approval at the extraordinary general meeting of the stockholders of CHW held on July 28, 2022 (the “Special Meeting”), the Company changed its name to Wag! Group Co. and effectively assumed all of CHW’s material operations. For more information regarding the CHW Business Combination, refer to Note 3, Business Combination with CHW , to the Consolidated Financial Statements included in the 2023 10-K. Earnout Compensation In connection with the CHW Business Combination, Legacy Wag! stockholders and certain members of management and employees of Legacy Wag! that held either a share of common stock, a Legacy Wag! Option or a Legacy Wag! RSU Award at the date of the Merger have the contingent right to Earnout Shares. The aggregate number of Earnout Shares and Management Earnout Shares is 10,000,000 and 5,000,000 shares of Wag! common stock, respectively. The Earnout Shares will be issued only if certain Wag! share price conditions are met over a three-year period from the Merger Date. The Earnout Shares are subject to the occurrence of certain triggering events based on a three-year period from the Merger Date as defined in the CHW Business Combination Agreement as: 1. 5,000,000 shares are earned if the stock price of the Company is or exceeds $12.50 for 20 out of any 30 consecutive trading days (“Triggering Event I”) 2. 5,000,000 shares are earned if the stock price of the Company is or exceeds $15.00 for 20 out of any 30 consecutive trading days (“Triggering Event II”); and 3. 5,000,000 shares are earned if the stock price of the Company is or exceeds $18.00 for 20 out of any 30 consecutive trading days (“Triggering Event III”) (collectively, the “Triggering Events”). Additionally, if there is a change of control transaction, the agreed upon selling price of the Company on a per share basis, would be the fair value of the shares inclusive of the resulting triggered Earnout Shares upon consummation of the proposed transaction. The per share price in a change in control would be used to determine whether the Triggering Events have been met, and depending on the per share price, a certain number of shares will be issued. The Earnout Shares and Management Earnout Shares are classified as equity transactions at initial issuance and at settlement when and if the triggering conditions are met. The Earnout Shares are equity-classified since they do not meet the liability classification criteria outlined in FASB ASC Topic 480, Distinguishing Liabilities from Equity , and are both (i) indexed to the Company’s own shares and (ii) meet the criteria for equity classification. Until the shares are issued upon a Triggering Event, the Earnout Shares are not included in shares outstanding. As of the date of the CHW Business Combination, the Earnout Share awards had a total fair value of $23.9 million determined using a Monte Carlo fair value methodology in each of the $12.50, $15.00, and $18.00 Earnout tranches multiplied by the number of Earnout Shares allocated to each individual pursuant to the calculation defined in the CHW Business Combination Agreement.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following tables provide information about the Company’s financial instruments that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation techniques utilized to determine such values as of September 30, 2024 and December 31, 2023: September 30, 2024 Level 1 Level 2 Level 3 Total (in thousands) Assets: Cash equivalents: Money market funds $ 4,832 $ — $ — $ 4,832 Total cash equivalents 4,832 — — 4,832 Total assets at fair value $ 4,832 $ — $ — $ 4,832 December 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Assets: Cash equivalents: Money market funds $ 11,388 $ — $ — $ 11,388 Total cash equivalents 11,388 — — 11,388 Total assets at fair value $ 11,388 $ — $ — $ 11,388 The Company’s money market funds were valued using Level 1 inputs because they were valued using quoted prices in active markets. As of September 30, 2024 and December 31, 2023, the Company’s cash equivalents approximated their estimated fair value. As such, there are no unrealized gains or losses related to the Company’s cash equivalents.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill recorded in connection with the Company’s acquisitions is primarily attributable to the assembled workforce and anticipated operational synergies. Goodwill is reviewed for impairment at least annually, absent any interim indicators of impairment. Goodwill was $4.6 million as of both September 30, 2024 and December 31, 2023, respectively. There were no additions to or impairments of goodwill during the nine months ended September 30, 2024. The gross carrying amounts and accumulated amortization of the Company’s intangible assets with determinable lives as of September 30, 2024 and December 31, 2023 were as follows: September 30, 2024 Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) Finite-lived intangible assets: Customer relationships and licenses $ 7,686 $ (2,398) $ 5,288 Media brand 1,250 (521) 729 Developed technology 1,073 (669) 404 Trademarks 1,052 (338) 714 Pharmacy board licenses 5 (5) — Total finite-lived intangible assets 11,066 (3,931) 7,135 Indefinite-lived intangible assets 177 — 177 Total intangible assets $ 11,243 $ (3,931) $ 7,312 December 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) Finite-lived intangible assets: Customer relationships and licenses $ 7,686 $ (1,550) $ 6,136 Media brand 1,250 (52) 1,198 Developed technology 1,073 (479) 594 Trademarks 1,052 (201) 851 Pharmacy board licenses 5 (5) — Total finite-lived intangible assets 11,066 (2,287) 8,779 Indefinite-lived intangible assets 49 — 49 Total intangible assets $ 11,115 $ (2,287) $ 8,828 Amortization expense related to customer relationships and licenses, media brand, developed technology, trademarks, and pharmacy board licenses is recorded in depreciation and amortization within the Company’s condensed consolidated statements of operations. Amortization expense of intangible assets with determinable lives was $0.5 million and $0.4 million for the three months ended September 30, 2024 and 2023, respectively, and $1.6 million and $1.1 million for the nine months ended September 30, 2024 and 2023, respectively.

Contract Liabilities

Contract Liabilities	9 Months Ended
	Sep. 30, 2024
Contract with Customer, Liability [Abstract]
Contract Liabilities	Contract Liabilities The timing of Services revenue recognition may differ from the timing of invoicing to or collections from customers. The Company’s contract liabilities balance, which is included in Deferred revenue within the Company’s condensed consolidated balance sheets, is primarily comprised of unredeemed gift cards, prepayments received from consumers for Wag! Premium subscriptions, and certain consumer credits for which the revenue is recognized over time as they are used for services on its platform. The contract liabilities balance was $1.8 million and $1.8 million as of September 30, 2024 and December 31, 2023, respectively. Revenues recognized related to the Company’s contract liabilities as of the beginning of the year was $0.2 million and $0.7 million for the three months ended September 30, 2024 and 2023, respectively, and $0.9 million and $1.6 million for the nine months ended September 30, 2024 and 2023, respectively.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt Paycheck Protection Program Loan On August 5, 2020, the Company received loan proceeds of approximately $5.1 million from a financial institution pursuant to the Paycheck Protection Program (the “PPP Loan”) established by the Coronavirus Aid, Relief, and Economic Security Act, of which $3.5 million was subsequently forgiven. The PPP Loan matures on August 5, 2025 and bears interest at a fixed rate of 1.00%. Principal and interest payments are payable monthly. During the nine months ended September 30, 2024 and 2023, the Company repaid a total amount of $0.3 million and $0.3 million, respectively, on amounts outstanding under the PPP Loan. As of September 30, 2024 and December 31, 2023, the amount outstanding under the PPP Loan was $0.4 million and $0.8 million, respectively. During the three and nine months ended September 30, 2024 and 2023, the Company recognized immaterial amounts of interest expense relating to the PPP Loan. Blue Torch Financing and Warrant Agreement On August 9, 2022, the Company entered into a financing agreement and warrant agreement with Blue Torch Finance, LLC (together with its affiliated funds and any other parties providing a commitment thereunder, including any additional lenders, agents, arrangers or other parties joined thereto after the date thereof, collectively, “Blue Torch”), pursuant to which, among other things, Blue Torch agreed to extend an approximately $32.2 million senior secured term loan (the “Financing Agreement”). The Financing Agreement is secured by a first priority security interest in substantially all assets of the Company and its subsidiaries. The Financing Agreement bears interest at a floating rate of interest equal to, at the Company’s option, Secured Overnight Financing Rate (“SOFR”) plus 10.00% per annum or the reference rate plus 9.00% per annum, with the reference rate defined as the greatest of: • 2.00% per annum; • the federal funds effective rate plus 0.50% per annum; • one-month SOFR plus 1.00% per annum; and • the prime rate announced by the Wall Street Journal from time to time. SOFR will be subject to a floor of 1.00% per annum, and the reference rate will be subject to a floor of 2.00% per annum. Interest will be payable in arrears at the end of each SOFR interest period (but at least every three months) for SOFR borrowings and quarterly in arrears for reference rate borrowings. The Financing Agreement matures in three years after the Merger Date and is subject to quarterly amortization payments of principal, in an aggregate amount equal to 2.00% of the outstanding principal amount in the first year after closing, 3.00% of the outstanding principal amount in the second year after closing, and 5.00% of the outstanding principal amount in the third year after closing. The remaining outstanding principal balance of the Financing Agreement is due and payable in full on the maturity date. In addition to scheduled amortization payments, the Financing Agreement contains customary mandatory prepayment provisions that require principal prepayments of the loan upon certain triggering events, including receipt of asset sale proceeds outside of the ordinary course of business, receipt of certain insurance proceeds, and receipt of proceeds of non-permitted debt. The loan may also be voluntarily prepaid at any time, subject to the payment of a prepayment premium and a make-whole payment. The prepayment premium is payable for voluntary payments and certain mandatory prepayments, and is equal to: (i) an interest make-whole payment plus 3.00% of the principal amount of such prepayment in the first year after closing; (ii) 2.00% of the principal amount of such prepayment in the second year after closing; and (iii) 0% thereafter. The Financing Agreement contains customary representations and warranties, affirmative covenants, financial reporting requirements, negative covenants and events of default. The negative covenants impose restrictions on the ability of the Company and its subsidiaries to incur indebtedness, grant liens, make investments, make acquisitions, declare and pay restricted payments, prepay junior or subordinated debt, sell assets, and enter into transactions with affiliates, in each case, subject to certain customary exceptions. The Company’s obligations under the Financing Agreement are guaranteed by certain of its subsidiaries meeting materiality thresholds. Such obligations, including the guarantees, are secured by substantially all of the personal property of the Company and its subsidiary guarantors, including pursuant to a Security Agreement simultaneously entered into on August 9, 2022. The Financing Agreement establishes the following financial covenants: (i) the Company's trailing annual aggregate revenue shall exceed certain thresholds as of the end of each monthly computation period as defined therein; and (ii) liquidity shall not be less than $5 million at any time. The Company was in compliance with these covenants as of September 30, 2024. As of September 30, 2024 and December 31, 2023, the interest rate for borrowings under the Financing Agreement was 14.87% and 15.61%, respectively. During the nine months ended September 30, 2024, the Company repaid a total amount of $10.9 million on amounts outstanding under the Financing Agreement, which included prepayments of $10.0 million that were treated as an extinguishment of debt for accounting purposes and resulted in a $1.2 million loss on extinguishment of debt. During the nine months ended September 30, 2023, the Company repaid a total amount of $0.6 million on amounts outstanding under the Financing Agreement. As of September 30, 2024 and December 31, 2023, the amount outstanding under the Financing Agreement was $20.3 million and $31.2 million, respectively. During the three months ended September 30, 2024 and 2023, the Company recognized $1.0 million and $1.2 million, respectively, of interest expense relating to the Financing Agreement. During the nine months ended September 30, 2024 and 2023, the Company recognized $3.2 million and $3.7 million, respectively, of interest expense relating to the Financing Agreement. On the closing of the Financing Agreement, the Company also entered into the Lender Warrant Agreement with Vstock Transfer, LLC as warrant agent, pursuant to which affiliates of Blue Torch received 1,896,177 warrants to acquire common stock of the Company, par value $0.0001 per share (“Common Stock”), for $11.50 per whole share (such warrants, the “Lender Warrants”). The Lender Warrants were issued pursuant to the SPAC Warrant Agreement (as defined in the CHW Business Combination Agreement) and are subject to the terms and conditions thereof, as modified (whether reflected in the terms of the Lender Warrants issued on the Merger Date, or in an amendment to or exchange for the Lender Warrants consummated after the Merger Date) to provide that (i) the exercise period of the Lender Warrants will terminate on the earliest to occur of (x) the date that is ten years after completion of the CHW Business Combination, (y) liquidation of the Company, and (z) redemption of the Lender Warrants as provided in the SPAC Warrant Agreement (the “Lender Warrant Expiration Date”), (ii) Blue Torch has the ability to net exercise the Lender Warrants (based on the fair value of the stock at the time of net exercise, fair value being equal to the public trading price at the time of exercise) on a cashless basis, (iii) Blue Torch received the benefit of certain customary representations and warranties from the Company, and (iv) the Lender Warrants are not required to be registered under the Securities Act. At the date of issuance, the Company classified the Lender Warrants as equity and recognized them in additional paid-in capital within its condensed consolidated balance sheet. As the Lender Warrants were classified as equity, the proceeds were allocated based on the relative fair values of the financial instruments issued as a whole. Total Debt As of September 30, 2024, annual scheduled principal payments of debt were as follows: Amount (in thousands) 2024 $ 518 2025 20,227 Total principal payments $ 20,745

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal and Other Contingencies From time to time, the Company may be a party to litigation and subject to claims, including non-income tax audits, in the ordinary course of business. The Company accrues a liability when management believes information available to it prior to the issuance of the consolidated financial statements indicates it is probable a loss has been incurred as of the date of the consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although the results of litigation and claims cannot be predicted with certainty, management concluded that there was not a reasonable probability that it had incurred a material loss during the periods presented related to such loss contingencies. Therefore, the Company has not recorded a reserve for any such contingencies. Given the inherent uncertainties and unpredictability of litigation, the ultimate outcome of ongoing matters cannot be predicted with certainty but the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Regardless of the outcome, litigation can have an adverse impact on the Company because of judgment, defense, and settlement costs, diversion of management resources, and other factors. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances changes, or contingencies are resolved; such changes are recorded in the accompanying statements of operations during the period of the change and reflected in accrued expenses and other current liabilities on the accompanying consolidated balance sheets. The Company has been and continues to be involved in numerous legal proceedings related to Pet Caregiver classification. In California, Assembly Bill No. 5 (AB-5) implemented a presumption that workers are employees. However, AB-2257 exempts agencies providing referrals for certain animal services, including dog walking, from AB-5. The Company believes that it falls within this exemption. Nevertheless, the interpretation or enforcement of the exemption could change. The United States Department of Labor issued a new rule regarding the classification of workers as independent contractors or employees that went into effect in March 2024. The Company is evaluating any impact the new rule may have on its operations. The Company is subject to audits by taxing authorities and other forms of investigation, audit, or inquiry conducted by federal, state, or local governmental agencies. Due to the inherent uncertainties in the final outcome of such matters, the Company can give no assurance that it will prevail in such matters, which could have an adverse effect on the Company’s business. In addition, the Company may be subject to greater risk of legal claims or regulatory actions as it increases and continues its operations in jurisdictions where the laws and regulations governing online marketplaces or the employment classification of service providers who use online marketplaces are uncertain or unfavorable. In November 2019, California issued an assessment alleging various violations and penalties related to alleged misclassification of pet caregivers who use the Company’s platform as independent contractors. The Company has challenged both the legal basis and the amount of the assessment, of $1.7 million in unemployment insurance contributions for its independent contractors. In April 2022, the California Employment Development Department ("CA EDD") initiated a routine employment tax audit of the Company and alleges the Company owes approximately $1.3 million in additional unemployment insurance contributions for its independent contractors. The Company is engaged in ongoing discussions with the CA EDD and intends to defend itself vigorously in this pending matter. The Company believes given the inherent uncertainties of litigation, the outcome of this matter is not considered probable nor estimable and, therefore, the Company has not recorded a reserve. In August 2018, the New York State Department of Labor (“NY DOL”) issued an Investigation Report assessing the Company with approximately $0.2 million in unemployment insurance contributions for its independent contractors. In August 2023, the Company completed payments of $0.4 million to the NY DOL, which represented the amount of the assessment plus interest and was recognized in general and administrative expenses within the Company’s condensed consolidated statement of operations during the third quarter of 2023. In December 2019, Wag Hotels, Inc. filed a lawsuit against the Company alleging various claims related to breach of contract and trademark infringement. On June 29, 2023, the parties agreed to a settlement amount of $0.5 million to resolve all claims, with an initial payment up front and the remaining payments over 25 months. The settlement was executed on August 30, 2023. The $0.5 million was recognized in general and administrative expenses within the Company’s condensed consolidated statement of operations during the second quarter of 2023 and the Company has recorded a corresponding liability in Accrued expenses and other current liabilities and Other non-current liabilities within its condensed consolidated balance sheet as of September 30, 2024. In December 2023, the NY DOL issued an investigation report assessing the Company with approximately $1.8 million in unemployment insurance contributions, including interest and penalties, for its independent contractors. On January 19, 2024, the Company submitted a request for hearing contesting assessment. The Company believes given the inherent uncertainties of litigation, the outcome of this matter is not considered probable nor estimable and, therefore, the Company has not recorded a reserve. As of September 30, 2024, management did not believe that the outcome of pending matters would have a material effect on the Company’s financial position, results of operations, or cash flows.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	9 Months Ended
	Sep. 30, 2024
Stockholders' Equity Note [Abstract]
Stockholders' Equity (Deficit)	Stockholders’ Equity (Deficit) On July 18, 2024, the Company issued and sold an aggregate of 7.4 million shares of common stock at a price of $1.35 per share in a registered public offering. The aggregate net proceeds were approximately $8.6 million, after deducting offering costs of $0.8 million and underwriting discounts and commissions of $0.6 million. The Company used a portion of the net proceeds to repay indebtedness. Common Stock Warrants Prior to the Merger, CHW issued 12,500,000 of Public Warrants and 4,238,636 of Private Warrants (together, the “Warrants”) in connection with its initial public offering to CHW Acquisition Sponsor LLC, the sponsor of CHW. After consummation of the Merger on August 9, 2022, the 4,238,636 Private Warrants held by the Sponsor were exchanged for 3,895,564 warrants to purchase shares of common stock of the Company issuable upon the exercise of Private Placement Warrants originally issued to CHW and the 12,500,000 shares of common stock that are issuable upon the exercise of Public Warrants remained outstanding. Each whole warrant entitles the registered holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment, at any time commencing on September 8, 2022, which was the later of 30 days after the completion of the CHW Business Combination or 12 months from CHW's IPO closing date. The Warrants will expire on the fifth anniversary of the CHW Business Combination, or earlier upon redemption or liquidation. The Company may call the Warrants for redemption: • in whole or in part; • at a price of $0.01 per warrant; • upon a minimum of 20 days’ prior written notice of redemption; and • if, and only if, the reported last sale price of the Public Shares equals or exceeds $16.50 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders. If the Company calls the Warrants for redemption, management will have the option to require all holders that wish to exercise the public warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a share dividend, recapitalization, reorganization, merger or consolidation. However, the Warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Warrants. Management has concluded that the Warrants issued pursuant to the CHW IPO qualify for equity classification. Accumulated Other Comprehensive Income There were no changes in accumulated other comprehensive income for the three and nine months ended September 30, 2024 and 2023.

Revenues

Revenues	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenues	Revenues The following table presents the Company’s revenues disaggregated by offering: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, (in thousands) Services revenue $ 5,402 $ 6,551 $ 16,312 $ 18,159 Wellness revenue 6,464 13,546 33,779 39,426 Pet Food & Treats revenue 1,338 1,703 4,983 4,658 Total revenues $ 13,204 $ 21,800 $ 55,074 $ 62,243

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation The Company has stock-based compensation plans, which are more fully described in Note 12, Stock-Based Compensation , to the Consolidated Financial Statements included in the 2023 10-K. During the nine months ended September 30, 2024, the Company granted restricted stock units (“RSUs”) subject to service conditions. Stock Options The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the nine months ended September 30, 2024: Number of Options Outstanding Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life Aggregate Intrinsic Value(1) (in thousands) (in thousands) Outstanding as of December 31, 2023 6,163 $ 0.44 6.06 years $ 8,934 Granted — $ — Exercised (1,110) $ 0.10 Forfeited or expired (54) $ 0.93 Outstanding as of September 30, 2024 4,999 $ 0.51 5.39 years $ 3,237 Exercisable as of September 30, 2024 4,963 $ 0.51 5.38 years $ 3,216 Vested and expected to vest as of September 30, 2024 4,999 $ 0.51 5.39 years $ 3,237 (1) The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards. There were no stock options granted during the three and nine months ended September 30, 2024 and 2023. The total intrinsic value of stock options exercised during the three months ended September 30, 2024 and 2023 was immaterial. The total intrinsic value of stock options exercised during the nine months ended September 30, 2024 and 2023 was $1.9 million and $2.2 million, respectively. As of September 30, 2024, the total unrecognized compensation cost related to all nonvested stock options was immaterial and the related weighted-average period over which it is expected to be recognized was approximately 0.91 years. Restricted Stock Units The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the nine months ended September 30, 2024: Number of Shares Weighted-Average Grant Date Fair Value Per Share (in thousands) Outstanding and nonvested as of December 31, 2023 4,322 $ 2.39 Granted 3,338 $ 2.22 Vested (1,621) $ 2.39 Forfeited (60) $ 2.49 Outstanding and nonvested as of September 30, 2024 5,979 $ 2.29 The total vesting date fair value of RSUs which vested during the three months ended September 30, 2024 and 2023 was $0.8 million and $0.9 million, respectively. The total vesting date fair value of RSUs which vested during the nine months ended September 30, 2024 and 2023 was $2.2 million and $3.2 million, respectively. As of September 30, 2024, the total unrecognized compensation cost related to all nonvested RSUs was $11.8 million and the related weighted-average period over which it is expected to be recognized was approximately 1.87 years. Stock-Based Compensation Expense The following table provides information about stock-based compensation expense by financial statement line item: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, (in thousands) Platform operations and support $ 254 $ 209 $ 703 $ 815 Sales and marketing 292 174 782 533 General and administrative 1,301 682 3,314 2,180 Total stock-based compensation expense $ 1,847 $ 1,065 $ 4,799 $ 3,528

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The quarterly income tax provision reflects an estimate of the corresponding quarter’s state taxes in the United States. The provision for income tax expense for the three and nine months ended September 30, 2024 and 2023 was determined based upon estimates of the Company’s annual effective tax rate for the years ending December 31, 2024 and 2023, respectively. Since the Company is in a full valuation allowance position due to losses incurred since inception, the provision for taxes consists solely of certain state income taxes.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	Acquisitions Acquisition of Dog Food Advisor On January 5, 2023, the Company entered into an Asset Purchase Agreement with Clicks and Traffic LLC to purchase its Dog Food Advisor assets for cash consideration of $9.0 million. Of the $9.0 million of cash consideration, $8.1 million was paid on the acquisition date and the remaining $0.9 million was deposited into an escrow account as an indemnification holdback for a period of 12 months. No working capital was acquired as part of the transaction. The Company incurred less than $0.1 million in transaction-related costs during the first quarter of 2023 in connection with the acquisition, which are included in general and administrative expenses within the Company’s condensed consolidated statement of operations. The acquisition marked the Company’s entrance into the Pet Food & Treats market, in line with its strategy to be an all-inclusive, trusted partner for the premium Pet Parent. The assets acquired were recognized at fair value as of the date of the acquisition. During 2023, the Company finalized the analysis of the purchase price and no adjustments were made to the assessed fair values. The following table summarizes the final fair values assigned to the assets acquired: January 5, (in thousands) Intangible assets $ 5,950 Goodwill 3,050 Total purchase consideration $ 9,000 The table below summarizes the fair value and the estimated useful lives of the acquired intangible assets: January 5, Estimated Weighted-Average Useful Life (in thousands) Developed technology and website content $ 1,950 5 years Strategic customer relationships and subscriber lists 3,600 8 years Trademarks 400 10 years Total intangible assets $ 5,950 7 years Goodwill recognized as a result of this acquisition is deductible for tax purposes. Pro forma disclosures required under ASC 805-10-50 are not presented because the pro forma impacts on the current period and prior year comparable period are not material. Acquisition of maxbone On April 6, 2023, the Company acquired 100% of the outstanding equity interests of MaxBone, Inc. (“maxbone”), a top-tier digital platform for modern pet essentials, for cash consideration of $0.5 million and 0.1 million common shares with a fair value of $0.2 million as of the closing date. Of the $0.2 million of common stock consideration, $0.1 million was issued on the acquisition date and the remaining $0.1 million was issued after the indemnification holdback period expired 12 months after the acquisition close. The acquisition expanded the Company’s reach into the Pet Supplies market, while remaining committed to the needs and standards of the premium Pet Parent. Acquisition of WoofWoofTV On December 15, 2023, the Company acquired 100% of the outstanding equity interests of Rowlo Woof Limited (“WoofWoofTV”), a digital media publishing company focusing on content for dog lovers, for cash consideration of $1.3 million. Of the $1.3 million of cash consideration, $1.1 million was paid on the acquisition date and the remaining $0.2 million was deposited into an escrow account as an indemnification holdback for a period of 12 months. The Company accounted for the transaction as an asset acquisition, as substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset. The table below summarizes the fair value and the estimated useful life of the acquired intangible asset: December 15, Estimated Weighted-Average Useful Life (in thousands) Media brand $ 1,250 2 years Total intangible assets $ 1,250 2 years

Loss Per Share

Loss Per Share	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Loss Per Share	Loss Per Share The following securities have been excluded from the computation of diluted loss per share for the periods presented because including them would have been anti-dilutive: Nine Months Ended September 30, September 30, (in thousands) Earnout Shares 15,000 15,000 Options and RSUs issued and outstanding 10,978 10,896 Warrants issued and outstanding 18,292 18,292 Shares related to acquisition indemnification holdback — 51 Total 44,270 44,239 All unvested Earnout Shares are excluded from basic and diluted loss per share as such shares are contingently issuable only when the share price of the Company’s common stock exceeds specified thresholds, which had not been achieved as of September 30, 2024.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net loss	$ (6,262)	$ (2,251)	$ (4,241)	$ (2,196)	$ (3,869)	$ (3,787)	$ (12,754)	$ (9,852)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2024 shares	Sep. 30, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
David Cane [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 5, 2024, David Cane, our Chief Customer Officer, adopted a 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 99,328 shares of common stock. The trading plan is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading plan is until December 12, 2025, or earlier if all transactions under the trading plan are completed.
Name	David Cane
Title	Chief Customer Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 5, 2024
Expiration Date	December 12, 2025
Arrangement Duration	463 days
Aggregate Available	99,328	99,328

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The unaudited condensed consolidated interim financial information of the Company has been prepared in accordance with Article 10 of the Securities and Exchange Commission’s (“SEC”) Regulation S-X. Accordingly, as permitted by Article 10 of Regulation S-X, it does not include all of the information required by generally accepted accounting principles in the U.S. (“U.S. GAAP”) for complete financial statements. The condensed consolidated balance sheet as of December 31, 2023 was derived from the audited financial statements at that date and does not include all the disclosures required by U.S. GAAP, as permitted by Article 10 of Regulation S-X. The Company’s unaudited condensed consolidated financial statements as of September 30, 2024 and for the three and nine months ended September 30, 2024 and 2023 include Wag! Group Co. and all of its subsidiaries. In the opinion of management, the accompanying financial information contains all adjustments, consisting of normal recurring adjustments, necessary to state fairly the Company’s unaudited condensed consolidated financial statements as of September 30, 2024 and for the three and nine months ended September 30, 2024 and 2023. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 10-K”). Operating results for the three and nine months ended September 30, 2024 and 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenues and expenses. Actual results could differ from those estimates. Significant items subject to estimates and assumptions include, but are not limited to, fair values of financial instruments, valuation of intangible assets acquired, valuation of stock-based compensation and warrants, and the valuation allowance for deferred income taxes. Actual results may differ from these estimates.
Recently Adopted Accounting Pronouncements and New Accounting Pronouncements	Recently Adopted Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). This ASU simplifies the accounting for convertible instruments by eliminating certain accounting models, resulting in fewer embedded conversion features being separately recognized from the host contract, and also amends the guidance for derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. Additionally, the amendments in this ASU affect the diluted earnings per share (“EPS”) calculation for convertible instruments. It requires that the effect of potential share settlement be included in the diluted EPS calculation when a convertible instrument may be settled in cash or shares; the if-converted method as opposed to the treasury stock method is required to calculate diluted EPS for these types of convertible instruments. The amendments in this update are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The adoption of this guidance during the first quarter of 2024 did not have a material impact on the Company’s condensed consolidated financial statements. New Accounting Pronouncements In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). This ASU improves reportable segment disclosures, primarily through enhanced disclosures about significant segment expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the potential impact of this adoption on its condensed consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). This ASU improves the transparency of income tax disclosures by requiring: (1) consistent categories and greater disaggregation of information in the rate reconciliation, and (2) income taxes paid disaggregated by jurisdiction. Additionally, the amendments in this ASU improve the effectiveness and comparability of disclosures by: (1) adding disclosures of pretax income (or loss) and income tax expense (or benefit) to be consistent with U.S. Securities and Exchange Commission (“SEC”) Regulation S-X, and (2) removing disclosures that no longer are considered cost beneficial or relevant. The amendments in this update are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the potential impact of this adoption on its condensed consolidated financial statements. In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”). This ASU improves financial reporting by requiring that public business entities disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods that is generally not presented in the financial statements today. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is evaluating the potential impact of this adoption on its condensed consolidated financial statements.
Equity Method Investment	Equity Method Investment During the fourth quarter of 2022, the Company’s subsidiary, Compare Pet Insurance Services, Inc., entered into an agreement to invest $1.5 million for 49% ownership in a new limited liability company, which was funded in the first quarter of 2023. The investment was accounted for as an equity method investment, with the Company’s proportionate share of the investee’s net income recognized in equity in net earnings of equity method investment within the Company’s consolidated statement of operations, as the Company had less than 50% ownership and did not control the entity. During the nine months ended September 30, 2024, the Company did not recognize any activity within its condensed consolidated statements of operations related to the equity method investee. During the third quarter of 2023, the Company acquired the remaining 51% ownership of the limited liability company for an aggregate purchase price of approximately $2.2 million. The Company accounted for the transaction as an asset acquisition using the cost accumulation model to determine the cost to be allocated to the assets acquired, which resulted in the derecognition of royalties payable to the equity method investee of approximately $1.8 million and the recognition of intangible assets acquired of approximately $0.2 million and cash acquired of $2.5 million. As a result of the transaction, the limited liability company became a wholly-owned subsidiary of the Company and the Company began consolidating the entity as part of its condensed consolidated financial statements.
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with FASB Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers . Through its Services offerings, the Company principally generates Services revenue from service fees charged to Pet Caregivers to successfully complete a pet care service for a Pet Parent via the platform. The Company also generates revenue from subscription fees paid by Pet Parents for Wag! Premium and fees paid by Pet Caregivers to join the platform. Additionally, through its Wellness and Pet Food & Treat offerings, the Company generates revenue through commission fees paid by third-party service partners in the form of “revenue-per-action” or conversion activity defined in our agreements with the respective third-party service partner. For some of the Company’s arrangements with third-party service partners, the transaction price is considered variable, and an estimate of the transaction price is recorded when the action occurs. The estimated transaction price used in the variable consideration is based on historical data with the respective third-party service partner and the consideration is measured and settled monthly. The Company enters into terms of service with Pet Caregivers and Pet Parents to use the platform (“Terms of Service Agreements”), as well as an Independent Contractor Agreement (“ICA”) with Pet Caregivers (the ICA, together with the Terms of Service Agreements, the “Agreements”). The Agreements govern the fees the Company charges the Pet Caregivers and Pet Parents, where applicable, for each transaction. Upon acceptance of a transaction, Pet Caregivers agree to perform the services that are requested by a Pet Parent. The acceptance of a transaction request combined with the Agreements establishes enforceable rights and obligations for each transaction. A contract exists between the Company and its customers after both the Pet Caregivers and Pet Parent accept a transaction request and the Pet Caregivers ability to cancel the transaction lapses. For Wag! Wellness and Pet Food & Treat revenues, the Company enters into agreements with third-party service partners which define the action by a Pet Parent that results in the Company earning and receiving a commission fee from the third-party service partner. Wag!’s service obligations are performed, and revenue is recognized, for fees earned related to the facilitation and completion of a pet service transaction between the Pet Parent and the Pet Caregiver through the use of our platform. Revenue generated from the Company’s Wag! Premium subscription is recognized on a ratable basis over the contractual period, which is generally one month to one year depending on the type of subscription purchased by the Pet Parent. Prepaid subscription amounts are included in deferred revenue within the Company’s condensed consolidated balance sheets. Revenue related to the fees paid by the Pet Caregiver to join the platform are recognized upon processing of the applications. Wag! Wellness and Pet Food & Treat revenue performance obligations are completed, and revenue is recognized, when an end-user completes an action or conversion activity. Principal vs. Agent Considerations Judgment is required in determining whether the Company is the principal or agent in transactions with Pet Caregivers and Pet Parents. The Company evaluates the presentation of revenues on a gross or net basis based on whether the Company controls the service provided to the Pet Parent and is the principal (i.e., “gross”), or whether the Company arranges for other parties to provide the service to the Pet Parent and is an agent (i.e. “net”). The Company’s role in a transaction on the platform is to facilitate Pet Caregivers finding, applying, and completing a successful pet care service for a Pet Parent. The Company has concluded it is the agent in transactions with Pet Caregivers and Pet Parents because, among other factors, the Company’s role is to facilitate pet service opportunities; it is not responsible for and does not control the delivery of pet services provided by the Pet Caregivers to the Pet Parents. Gift Cards The Company sells gift cards that can be redeemed by Pet Parents through the platform. Proceeds from the sale of gift cards are deferred and recorded as contract liabilities in Deferred revenue within the Company’s condensed consolidated balance sheets until Pet Parents use the card to place orders on our platform. When gift cards are redeemed, revenue is recognized on a net basis as the difference between the amounts collected from the purchaser less amounts remitted to Pet Caregivers. Unused gift cards are included in Deferred revenue within the Company’s condensed consolidated balance sheets. The Company recognizes breakage revenue based on historical redemption patterns. Incentives The Company offers discounts and promotions to encourage use of the Company’s platform. These promotions are generally pricing actions in the form of discounts that reduce the price Pet Parents pay Pet Caregivers for services. These promotions result in a lower fee earned by the Company from the Pet Caregiver. Accordingly, the Company records the cost of these promotions as a reduction of revenues. Discounts on services offered through our subscription program are also recorded as a reduction of revenues.
Loss Per Share	Loss Per Share The Company follows the two-class method when computing loss per share when shares issued meet the definition of participating securities. The two-class method determines loss per share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Financial Assets	The following tables provide information about the Company’s financial instruments that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation techniques utilized to determine such values as of September 30, 2024 and December 31, 2023: September 30, 2024 Level 1 Level 2 Level 3 Total (in thousands) Assets: Cash equivalents: Money market funds $ 4,832 $ — $ — $ 4,832 Total cash equivalents 4,832 — — 4,832 Total assets at fair value $ 4,832 $ — $ — $ 4,832 December 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Assets: Cash equivalents: Money market funds $ 11,388 $ — $ — $ 11,388 Total cash equivalents 11,388 — — 11,388 Total assets at fair value $ 11,388 $ — $ — $ 11,388

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	The gross carrying amounts and accumulated amortization of the Company’s intangible assets with determinable lives as of September 30, 2024 and December 31, 2023 were as follows: September 30, 2024 Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) Finite-lived intangible assets: Customer relationships and licenses $ 7,686 $ (2,398) $ 5,288 Media brand 1,250 (521) 729 Developed technology 1,073 (669) 404 Trademarks 1,052 (338) 714 Pharmacy board licenses 5 (5) — Total finite-lived intangible assets 11,066 (3,931) 7,135 Indefinite-lived intangible assets 177 — 177 Total intangible assets $ 11,243 $ (3,931) $ 7,312 December 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) Finite-lived intangible assets: Customer relationships and licenses $ 7,686 $ (1,550) $ 6,136 Media brand 1,250 (52) 1,198 Developed technology 1,073 (479) 594 Trademarks 1,052 (201) 851 Pharmacy board licenses 5 (5) — Total finite-lived intangible assets 11,066 (2,287) 8,779 Indefinite-lived intangible assets 49 — 49 Total intangible assets $ 11,115 $ (2,287) $ 8,828
Schedule of Indefinite-Lived Intangible Assets	The gross carrying amounts and accumulated amortization of the Company’s intangible assets with determinable lives as of September 30, 2024 and December 31, 2023 were as follows: September 30, 2024 Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) Finite-lived intangible assets: Customer relationships and licenses $ 7,686 $ (2,398) $ 5,288 Media brand 1,250 (521) 729 Developed technology 1,073 (669) 404 Trademarks 1,052 (338) 714 Pharmacy board licenses 5 (5) — Total finite-lived intangible assets 11,066 (3,931) 7,135 Indefinite-lived intangible assets 177 — 177 Total intangible assets $ 11,243 $ (3,931) $ 7,312 December 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) Finite-lived intangible assets: Customer relationships and licenses $ 7,686 $ (1,550) $ 6,136 Media brand 1,250 (52) 1,198 Developed technology 1,073 (479) 594 Trademarks 1,052 (201) 851 Pharmacy board licenses 5 (5) — Total finite-lived intangible assets 11,066 (2,287) 8,779 Indefinite-lived intangible assets 49 — 49 Total intangible assets $ 11,115 $ (2,287) $ 8,828

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Future Minimum Payments	As of September 30, 2024, annual scheduled principal payments of debt were as follows: Amount (in thousands) 2024 $ 518 2025 20,227 Total principal payments $ 20,745

Revenues (Tables)

Revenues (Tables)	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenues	The following table presents the Company’s revenues disaggregated by offering: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, (in thousands) Services revenue $ 5,402 $ 6,551 $ 16,312 $ 18,159 Wellness revenue 6,464 13,546 33,779 39,426 Pet Food & Treats revenue 1,338 1,703 4,983 4,658 Total revenues $ 13,204 $ 21,800 $ 55,074 $ 62,243

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Option Activity	The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the nine months ended September 30, 2024: Number of Options Outstanding Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life Aggregate Intrinsic Value(1) (in thousands) (in thousands) Outstanding as of December 31, 2023 6,163 $ 0.44 6.06 years $ 8,934 Granted — $ — Exercised (1,110) $ 0.10 Forfeited or expired (54) $ 0.93 Outstanding as of September 30, 2024 4,999 $ 0.51 5.39 years $ 3,237 Exercisable as of September 30, 2024 4,963 $ 0.51 5.38 years $ 3,216 Vested and expected to vest as of September 30, 2024 4,999 $ 0.51 5.39 years $ 3,237 (1) The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.
Schedule of Restricted Stock Activity	The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the nine months ended September 30, 2024: Number of Shares Weighted-Average Grant Date Fair Value Per Share (in thousands) Outstanding and nonvested as of December 31, 2023 4,322 $ 2.39 Granted 3,338 $ 2.22 Vested (1,621) $ 2.39 Forfeited (60) $ 2.49 Outstanding and nonvested as of September 30, 2024 5,979 $ 2.29
Schedule of Total Stock-Based Compensation Expense by Function	The following table provides information about stock-based compensation expense by financial statement line item: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, (in thousands) Platform operations and support $ 254 $ 209 $ 703 $ 815 Sales and marketing 292 174 782 533 General and administrative 1,301 682 3,314 2,180 Total stock-based compensation expense $ 1,847 $ 1,065 $ 4,799 $ 3,528

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Purchase Consideration	The assets acquired were recognized at fair value as of the date of the acquisition. During 2023, the Company finalized the analysis of the purchase price and no adjustments were made to the assessed fair values. The following table summarizes the final fair values assigned to the assets acquired: January 5, (in thousands) Intangible assets $ 5,950 Goodwill 3,050 Total purchase consideration $ 9,000
Schedule of Estimated Useful Lives of Acquired Intangible Assets	The table below summarizes the fair value and the estimated useful lives of the acquired intangible assets: January 5, Estimated Weighted-Average Useful Life (in thousands) Developed technology and website content $ 1,950 5 years Strategic customer relationships and subscriber lists 3,600 8 years Trademarks 400 10 years Total intangible assets $ 5,950 7 years The table below summarizes the fair value and the estimated useful life of the acquired intangible asset: December 15, Estimated Weighted-Average Useful Life (in thousands) Media brand $ 1,250 2 years Total intangible assets $ 1,250 2 years

Loss Per Share (Tables)

Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share	The following securities have been excluded from the computation of diluted loss per share for the periods presented because including them would have been anti-dilutive: Nine Months Ended September 30, September 30, (in thousands) Earnout Shares 15,000 15,000 Options and RSUs issued and outstanding 10,978 10,896 Warrants issued and outstanding 18,292 18,292 Shares related to acquisition indemnification holdback — 51 Total 44,270 44,239

Significant Accounting Polici_3

Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended							9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cash and cash equivalents	$ 8,445							$ 8,445		$ 18,323
Accounts receivable, net	6,548							6,548		10,023
Principal and interest payments balance	20,745							20,745
Net loss	6,262	$ 2,251	$ 4,241	$ 2,196	$ 3,869	$ 3,787		12,754	$ 9,852
Net cash used in operating activities								(5,274)	$ (4,624)
Initial investment							$ 1,500
The Credit Facility | Secured Debt
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Principal and interest payments balance	20,300							20,300		31,200
PPP Loan
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Principal and interest payments balance	$ 400							$ 400		$ 800
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Ratable basis over contractual period								1 month
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Ratable basis over contractual period								1 year
Limited Liability Equity Method Investment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Outstanding ownership percentage acquired				51%					51%
Intangible assets acquired				$ 2,200
Recognition of intangible assets acquired				200
Cash acquired				2,500
New Limited Liability Company
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Ownership percentage							49%
Derecognition of royalties payable				$ 1,800

Business Combination with CHW -

Business Combination with CHW - CHW Narrative (Details) $ / shares in Units, $ in Millions	Aug. 09, 2022 USD ($) tradingDay $ / shares shares
Schedule Of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, equity, triggering event period	3 years
Fair value of earnout share awards | $	$ 23.9
Earnout Consideration Triggering Event, One
Schedule Of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, equity, stock price trigger (in dollars per share) | $ / shares	$ 12.50
Earnout Consideration Triggering Event, Two
Schedule Of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, equity, stock price trigger (in dollars per share) | $ / shares	15
Earnout Consideration Triggering Event, Three
Schedule Of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, equity, stock price trigger (in dollars per share) | $ / shares	$ 18
Earnout Shares
Schedule Of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, equity, shares (in shares) | shares	10,000,000
Reverse recapitalization, contingent consideration, equity, triggering event period	3 years
Earnout Shares | Earnout Consideration Triggering Event, One
Schedule Of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, equity, shares (in shares) | shares	5,000,000
Reverse recapitalization, contingent consideration, equity, stock price trigger (in dollars per share) | $ / shares	$ 12.50
Reverse recapitalization, contingent consideration, equity, threshold trading days | tradingDay	20
Reverse recapitalization, contingent consideration, equity, threshold trading day period | tradingDay	30
Earnout Shares | Earnout Consideration Triggering Event, Two
Schedule Of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, equity, shares (in shares) | shares	5,000,000
Reverse recapitalization, contingent consideration, equity, stock price trigger (in dollars per share) | $ / shares	$ 15
Reverse recapitalization, contingent consideration, equity, threshold trading days | tradingDay	20
Reverse recapitalization, contingent consideration, equity, threshold trading day period | tradingDay	30
Earnout Shares | Earnout Consideration Triggering Event, Three
Schedule Of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, equity, shares (in shares) | shares	5,000,000
Reverse recapitalization, contingent consideration, equity, stock price trigger (in dollars per share) | $ / shares	$ 18
Reverse recapitalization, contingent consideration, equity, threshold trading days | tradingDay	20
Reverse recapitalization, contingent consideration, equity, threshold trading day period | tradingDay	30
Management Earnout Shares
Schedule Of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, equity, shares (in shares) | shares	5,000,000

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Assets:
Total cash equivalents	$ 4,832	$ 11,388
Total assets at fair value	4,832	11,388
Level 1
Assets:
Total cash equivalents	4,832	11,388
Total assets at fair value	4,832	11,388
Level 2
Assets:
Total cash equivalents	0	0
Total assets at fair value	0	0
Level 3
Assets:
Total cash equivalents	0	0
Total assets at fair value	0	0
Money market funds
Assets:
Total cash equivalents	4,832	11,388
Money market funds | Level 1
Assets:
Total cash equivalents	4,832	11,388
Money market funds | Level 2
Assets:
Total cash equivalents	0	0
Money market funds | Level 3
Assets:
Total cash equivalents	$ 0	$ 0

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 4,646		$ 4,646		$ 4,646
Amortization expense	$ 500	$ 400	$ 1,600	$ 1,100

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Schedule of Gross Carrying Amounts and Accumulated Amortization (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Carrying Value	$ 11,066	$ 11,066
Finite-lived intangible assets, Accumulated Amortization	(3,931)	(2,287)
Finite-lived intangible assets, Net Carrying Amount	7,135	8,779
Indefinite-lived intangible assets	177	49
Total intangible assets	11,243	11,115
Intangible assets, net	7,312	8,828
Customer relationships and licenses
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Carrying Value	7,686	7,686
Finite-lived intangible assets, Accumulated Amortization	(2,398)	(1,550)
Finite-lived intangible assets, Net Carrying Amount	5,288	6,136
Media brand
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Carrying Value	1,250	1,250
Finite-lived intangible assets, Accumulated Amortization	(521)	(52)
Finite-lived intangible assets, Net Carrying Amount	729	1,198
Developed technology and website content
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Carrying Value	1,073	1,073
Finite-lived intangible assets, Accumulated Amortization	(669)	(479)
Finite-lived intangible assets, Net Carrying Amount	404	594
Trademarks
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Carrying Value	1,052	1,052
Finite-lived intangible assets, Accumulated Amortization	(338)	(201)
Finite-lived intangible assets, Net Carrying Amount	714	851
Pharmacy board licenses
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Carrying Value	5	5
Finite-lived intangible assets, Accumulated Amortization	(5)	(5)
Finite-lived intangible assets, Net Carrying Amount	$ 0	$ 0

Contract Liabilities (Details)

Contract Liabilities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Contract with Customer, Liability [Abstract]
Contract liabilities	$ 1.8		$ 1.8		$ 1.8
Amount of revenue included in contract with customer liability	$ 0.2	$ 0.7	$ 0.9	$ 1.6

Long-Term Debt - PPP Loan (Deta

Long-Term Debt - PPP Loan (Details) - USD ($) $ in Thousands		9 Months Ended
	Aug. 05, 2020	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Debt Instrument [Line Items]
Principal and interest payments balance		$ 20,745
PPP Loan
Debt Instrument [Line Items]
Loan proceeds	$ 5,100
Applied loan forgiveness amount	$ 3,500
Fixed annual interest rate	1%
Repayment of debt		300	$ 300
Principal and interest payments balance		$ 400		$ 800

Long-Term Debt - Blue Torch Fin

Long-Term Debt - Blue Torch Financing and Warrant Agreement (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
	Aug. 09, 2022	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Debt Instrument [Line Items]
Liquidity	$ 5,000
Loss on extinguishment of debt		$ 454	$ 0	$ 1,180	$ 0
Principal and interest payments balance		$ 20,745		$ 20,745
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001		$ 0.0001		$ 0.0001
Lender Warrants
Debt Instrument [Line Items]
Warrants outstanding (in shares)	1,896,177
Weighted average exercise price for the warrants (in dollars per share)	$ 11.50
Warrant termination term if earliest occurrence	10 years
The Credit Facility
Debt Instrument [Line Items]
Extinguishment of debt				$ 10,000
Loss on extinguishment of debt				$ 1,200
The Credit Facility | Secured Debt
Debt Instrument [Line Items]
Loan proceeds	$ 32,200
Fixed annual interest rate		14.87%		14.87%		15.61%
Repayment of debt				$ 10,900	600
Principal and interest payments balance		$ 20,300		20,300		$ 31,200
Interest expense, debt		$ 1,000	$ 1,200	$ 3,200	$ 3,700
The Credit Facility | Secured Debt | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Term of loan (in years)	3 years
Fixed annual interest rate	2%
Prepayment amounts	3%
The Credit Facility | Secured Debt | Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Fixed annual interest rate	3%
Prepayment amounts	2%
The Credit Facility | Secured Debt | Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Fixed annual interest rate	5%
Prepayment amounts	0%
The Credit Facility | Secured Debt | Variable Rate Component One
Debt Instrument [Line Items]
Basis rates	2%
The Credit Facility | Secured Debt | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Basis rates	10%
SOFR floor rate	1%
The Credit Facility | Secured Debt | Secured Overnight Financing Rate (SOFR) | Variable Rate Component Three
Debt Instrument [Line Items]
Basis rates	1%
The Credit Facility | Secured Debt | Reference Rate
Debt Instrument [Line Items]
Basis rates	9%
SOFR floor rate	2%
The Credit Facility | Secured Debt | Federal Funds Effective Rate | Variable Rate Component Two
Debt Instrument [Line Items]
Basis rates	0.50%

Long-Term Debt - Schedule of Fu

Long-Term Debt - Schedule of Future Minimum Payments (Details) $ in Thousands	Sep. 30, 2024 USD ($)
Debt Disclosure [Abstract]
2024	$ 518
2025	20,227
Total principal payments	$ 20,745

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions		1 Months Ended	3 Months Ended
	Jun. 29, 2023	Aug. 31, 2023	Jun. 30, 2023	Dec. 31, 2023	Apr. 30, 2022	Nov. 30, 2019	Aug. 31, 2018
Wag Hotels, Inc Litigation
Loss Contingencies [Line Items]
Settlement amount	$ 0.5
Remaining payments term	25 months
Settlement amount recognized as accrued liability			$ 0.5
Unemployment Insurance Contributions, Independent Contractors
Loss Contingencies [Line Items]
Unemployment insurance contributions				$ 1.8	$ 1.3	$ 1.7	$ 0.2
Amount of claim paid		$ 0.4

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) - Narrative (Details) $ / shares in Units, $ in Millions			9 Months Ended
	Jul. 18, 2024 USD ($) $ / shares shares	Aug. 09, 2022 $ / shares shares	Sep. 30, 2024 day $ / shares	Aug. 08, 2022 shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share) | $ / shares			$ 16.50
Threshold trading days for redemption of public warrants | day			20
Number of trading days over which the reported sale price is measured when determining the redemption price | day			30
Public Warrants
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding (in shares)				12,500,000
Class of warrant or right, issuable (in shares)		12,500,000
Number of shares issuable per warrant (in shares)		1
Weighted average exercise price for the warrants (in dollars per share) | $ / shares		$ 11.50
Redemption price per public warrant (in dollars per share) | $ / shares			$ 0.01
Redemption period			20 days
Private Warrants
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding (in shares)				4,238,636
Class of warrant or right, cancelled (in shares)		4,238,636
Class of warrant or right, issuable (in shares)		3,895,564
CHW Warrants
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Adjustment term option upon completion of business combination		30 days
Adjustment term option upon IPO closing date		12 months
Public Stock Offering
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares issued (in shares)	7,400,000
Price per share (in dollars per share) | $ / shares	$ 1.35
Aggregate net proceeds | $	$ 8.6
Deducted offering costs | $	0.8
Underwriting discounts and commissions | $	$ 0.6

Revenues - Schedule of Disaggre

Revenues - Schedule of Disaggregation of Revenues (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Total revenues	$ 13,204	$ 21,800	$ 55,074	$ 62,243
Services revenue
Disaggregation of Revenue [Line Items]
Total revenues	5,402	6,551	16,312	18,159
Wellness revenue
Disaggregation of Revenue [Line Items]
Total revenues	6,464	13,546	33,779	39,426
Pet Food & Treats revenue
Disaggregation of Revenue [Line Items]
Total revenues	$ 1,338	$ 1,703	$ 4,983	$ 4,658

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Number of Options Outstanding
Outstanding beginning (in shares)	6,163
Granted (in shares)	0
Exercised (in shares)	(1,110)
Forfeited or expired (in shares)	(54)
Outstanding ending (in shares)	4,999	6,163
Exercisable (in shares)	4,963
Vested and expected to vest (in shares)	4,999
Weighted-Average Exercise Price
Outstanding, beginning (in dollars per share)	$ 0.44
Granted (in dollars per share)	0
Exercised (in dollars per share)	0.10
Forfeited or expired (in dollars per share)	0.93
Outstanding, ending (in dollars per share)	0.51	$ 0.44
Exercisable (in dollars per share)	0.51
Vested and expected to vest (in dollars per share)	$ 0.51
Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value
Weighted-Average Remaining Contractual Life, Outstanding	5 years 4 months 20 days	6 years 21 days
Weighted-Average Remaining Contractual Life, Exercisable	5 years 4 months 17 days
Weighted-Average Remaining Contractual Life, Vested and expected to vest	5 years 4 months 20 days
Aggregate Intrinsic Value, Outstanding	$ 3,237	$ 8,934
Aggregate Intrinsic Value, Exercisable	3,216
Aggregate Intrinsic Value, Vested and expected to vest	$ 3,237

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Issuance of common stock from exercise of stock options and vesting of restricted stock units	$ 0	$ 0	$ 1,900	$ 2,200
Aggregate stock compensation expense remaining to be amortized	0		$ 0
Options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock compensation expense expected to be recognized over a weighted average period			10 months 28 days
Restricted Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock compensation expense expected to be recognized over a weighted average period			1 year 10 months 13 days
Vesting date fair value of RSUs	800	$ 900	$ 2,200	$ 3,200
Unrecognized expense related to unvested restricted stock	$ 11,800		$ 11,800

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of Restricted Stock Activity (Details) - Restricted Stock shares in Thousands	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Number of Shares
Unvested at beginning (in shares) | shares	4,322
Grants (in shares) | shares	3,338
Vested (in shares) | shares	(1,621)
Forfeited (in shares) | shares	(60)
Unvested at ending (in shares) | shares	5,979
Weighted-Average Grant Date Fair Value Per Share
Unvested at beginning (in dollars per share) | $ / shares	$ 2.39
Grants (in dollars per share) | $ / shares	2.22
Vested (in dollars per share) | $ / shares	2.39
Forfeited (in dollars per share) | $ / shares	2.49
Unvested at ending (in dollars per share) | $ / shares	$ 2.29

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense by Function (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation expense	$ 1,847	$ 1,065	$ 4,799	$ 3,528
Platform operations and support
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation expense	254	209	703	815
Sales and marketing
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation expense	292	174	782	533
General and administrative
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation expense	$ 1,301	$ 682	$ 3,314	$ 2,180

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($)					3 Months Ended
	Apr. 06, 2024	Dec. 15, 2023	Apr. 06, 2023	Jan. 05, 2023	Mar. 31, 2023
Woof Woof TV
Business Acquisition, Contingent Consideration [Line Items]
Amount deposited into an escrow account		$ 200,000
Total intangible assets		$ 1,250,000
Asset acquisition of entity interests		100%
Intangible assets acquired		$ 1,300,000
Payments for asset acquisitions		$ 1,100,000
DFA
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration				$ 9,000,000
Cash consideration				8,100,000
Amount deposited into an escrow account				900,000
Working capital				0
Transaction-related costs					$ 100,000
Total intangible assets				$ 5,950,000
MaxBone
Business Acquisition, Contingent Consideration [Line Items]
Outstanding equity interest			100%
Maxbone
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration			$ 500,000
Common stock consideration (in shares)			100,000
Total intangible assets			$ 200,000
Common stock consideration			200,000
Consideration issued	$ 100,000		$ 100,000

Acquisitions - Schedule of Purc

Acquisitions - Schedule of Purchase Consideration (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Jan. 05, 2023
Business Acquisition, Contingent Consideration [Line Items]
Goodwill	$ 4,646	$ 4,646
DFA
Business Acquisition, Contingent Consideration [Line Items]
Intangible assets			$ 5,950
Goodwill			3,050
Total purchase consideration			$ 9,000

Acquisitions - Schedule of Esti

Acquisitions - Schedule of Estimated Useful Lives of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 15, 2023	Jan. 05, 2023
Woof Woof TV
Business Acquisition, Contingent Consideration [Line Items]
Total intangible assets	$ 1,250
Estimated Weighted-Average Useful Life	2 years
Media brand | Woof Woof TV
Business Acquisition, Contingent Consideration [Line Items]
Total intangible assets	$ 1,250
Estimated Weighted-Average Useful Life	2 years
DFA
Business Acquisition, Contingent Consideration [Line Items]
Total intangible assets		$ 5,950
Estimated Weighted-Average Useful Life		7 years
DFA | Developed technology and website content
Business Acquisition, Contingent Consideration [Line Items]
Total intangible assets		$ 1,950
Estimated Weighted-Average Useful Life		5 years
DFA | Strategic customer relationships and subscriber lists
Business Acquisition, Contingent Consideration [Line Items]
Total intangible assets		$ 3,600
Estimated Weighted-Average Useful Life		8 years
DFA | Trademarks
Business Acquisition, Contingent Consideration [Line Items]
Total intangible assets		$ 400
Estimated Weighted-Average Useful Life		10 years

Loss Per Share - Schedule of An

Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	44,270	44,239
Earnout Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	15,000	15,000
Options and RSUs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	10,978	10,896
Warrants issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	18,292	18,292
Shares related to acquisition indemnification holdback
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	51